Milbhor D' Silva | Vice President, Product Safety & Pharmacovigilance
Astellas Pharma Global Development

Milbhor D’Silva is a transplant and multiorgan procurement surgeon by background. His clinical work was complemented by live animal research using solid organ models of transplantation. His pharmaceutical medicine career spans 14 years. Over this period he has worked with both, therapeutic drug development (Novartis, Abbott) and medical diagnostic imaging companies (GE-Healthcare-Medical Diagnostics) in both Europe and the US. His work has focused in supporting pre- and postmarketing projects, while working with Health Authorities. Of note, his work in the field of Xenotransplantation with Novartis allowed him the opportunity to engage with the FDA, CDC, WHO, and the UK health authority in the area of planning to mitigate risks following retroviral disease transmission through solid xenografting in humans. Milbhor D’Silva currently leads the Product Safety & Pharmacovigilance group in Astellas Pharma Global Development at Deerfield, IL. Outside of the pharmaceutical field, Milbhor’s interests allow him to be engaged in the work done by the Southern Poverty Law Center in the areas of fighting hate, teaching tolerance, and seeking justice.